| 000 | 01628 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513165154.0 | ||
| 264 | 0 | _c19990324 | |
| 008 | 199903s 0 0 eng d | ||
| 022 | _a0959-8138 | ||
| 024 | 7 |
_a10.1136/bmj.318.7182.502 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBardhan, K D | |
| 245 | 0 | 0 |
_aSymptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group. _h[electronic resource] |
| 260 |
_bBMJ (Clinical research ed.) _cFeb 1999 |
||
| 300 |
_a502-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Ulcer Agents _xtherapeutic use |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGastroesophageal Reflux _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOmeprazole _xtherapeutic use |
| 650 | 0 | 4 |
_aRanitidine _xtherapeutic use |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMüller-Lissner, S | |
| 700 | 1 | _aBigard, M A | |
| 700 | 1 | _aBianchi Porro, G | |
| 700 | 1 | _aPonce, J | |
| 700 | 1 | _aHosie, J | |
| 700 | 1 | _aScott, M | |
| 700 | 1 | _aWeir, D G | |
| 700 | 1 | _aGillon, K R | |
| 700 | 1 | _aPeacock, R A | |
| 700 | 1 | _aFulton, C | |
| 773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 318 _gno. 7182 _gp. 502-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.318.7182.502 _zAvailable from publisher's website |
| 999 |
_c9985617 _d9985617 |
||